Novel anti-fibrotic modalities for liver fibrosis: Molecular targeting and regenerative medicine in fibrosis therapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue SUPPL.2, 2012, Pages 85-88

  Inagaki, Yutaka ^a   Higashiyama, Reiichi ^a,c   Higashi, Kiyoshi ^b  

^a TOKAI UNIVERSITY   (Japan)

^b SUMITOMO CHEMICAL CO LTD   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bone marrow; Collagen; Liver fibrosis; Smad; Transforming growth factor

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; SCATTER FACTOR; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; Y BOX BINDING PROTEIN 1;

ARTICLE; BONE MARROW CELL; CELL MIGRATION; GENETIC TRANSCRIPTION; HUMAN; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REMISSION; STELLATE CELL;

EID: 84856962975     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.07006.x     Document Type: Article

References (18)

1. Inagaki Y, Okazaki I. Emerging insights into transforming growth factor-β Smad signal in hepatic fibrogenesis. Gut 2007; 56: 284-92.
2. Yoshiji H, Kuriyama S, Yoshii J etal. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001; 34: 745-50.
3. Terui Y, Saito T, Watanabe H etal. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology 2002; 36: 1022.
4. Yokohama S, Yoneda M, Haneda M etal. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 2004; 40: 1222-5.
5. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J. Biol. Chem. 1994; 269: 14828-34.
6. Zhang W, Ou J, Inagaki I, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of α2(I) collagen (COL1A2) transcription. J. Biol. Chem. 2000; 275: 39237-45.
7. Inagaki Y, Nemoto T, Nakao A etal. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J. Biol. Chem. 2001; 276: 16573-9.
8. Inagaki Y, Mamura M, Kanamaru Y etal. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J. Cell. Physiol. 2001; 187: 117-23.
9. Inagaki Y, Higashi K, Kushida M etal. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. Gastroenterology 2008; 134: 1180-90.
10. Higashi K, Inagaki Y, Suzuki N etal. Y-box binding protein YB-1 mediates transcriptional repression of human α2(I) collagen gene expression by interferon-γ. J. Biol. Chem. 2003; 278: 5156-62.
11. Higashi K, Inagaki Y, Fujimori K, Nakao A, Kaneko H, Nakatsuka I. Interferon-γ interferes with transforming growth factor-β signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem. 2003; 278: 43470-9.
12. Inagaki Y, Kushida M, Higashi K etal. Cell type-specific intervention of TGF-β/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 2005; 129: 259-68.
13. Hasegawa M, Matsushita Y, Horikawa M etal. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Arthritis Rheum. 2009; 60: 3465-75.
14. Higashi K, Tomigahara Y, Shiraki H etal. A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice. J. Biol. Chem. 2011; 286: 4485-92.
15. Higashiyama R, Inagaki Y, Hong YY etal. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007; 45: 213-22.
16. Piscaglia AC, Shupe TD, Oh S-H, Gasbarrini A, Petersen BE. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007; 133: 619-31.
17. Spahr L, Lambert J-F, Rubbia-Brandt L etal. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 2008; 48: 221-9.
18. Ogiso T, Nagaki M, Takai S etal. Granulocyte-colony stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1β. J. Hepatol. 2007; 47: 816-25.